Literature DB >> 6818318

Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.

G R Harriman, E R Podack, A I Braude, L C Corbeil, A F Esser, J G Curd.   

Abstract

Interaction of the human complement system in normal human serum (NHS) with serum-resistant and -sensitive Neisseria gonorrhoeae was evaluated to better understand the mechanism of serum-resistance. Complement activity (CH50) was depleted from NHS in a dose-dependent fashion by both serum-resistant and -sensitive N. gonorrhoeae. No detectable CH50 remained in NHS incubated with 10(9) colony-forming units (CFU)/ml serum of either resistant or sensitive strains. When smaller numbers of bacteria were incubated with NHS, lesser, yet comparable, amounts of CH50 were depleted by both resistant and sensitive strains. Hemolytic C2 activity was diminished by 33% in the case of resistant N. gonorrhoeae (10(8) CFU/ml serum) and by 48% in the case of a sensitive strain. No detectable decreases in hemolytic C4 or C7 activities were found with either sensitive or resistant strains at this concentration. Both resistant and sensitive strains activated C1s in NHS. Resistant strains specifically activated 19-21% of radiolabeled C1s in NHS, whereas sensitive strains activated 18-32%. Both resistant and sensitive strains also activated C5 in NHS. In binding assays using radiolabeled C5 and C9 in NHS, resistant and sensitive strains bound comparable amounts of C5 and C9. The number of bound C5 and C9 molecules varied according to the number of bacteria or amount of serum used in the assay. The ratio of C9/C5 bound to a sensitive strain was 6.8, and to a resistant strain was 8.2, suggesting that C5 and C9 were incorporated into membrane attack complexes (MAC). Electron microscopic examination of resistant and sensitive strains incubated with NHS revealed that MAC is bound to the surfaces of the resistant strain as well as the sensitive strain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818318      PMCID: PMC2186825          DOI: 10.1084/jem.156.4.1235

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Studies on the bactericidal reaction. II. Inhibition by antibody, and antibody requirements of the reaction.

Authors:  F L ADLER
Journal:  J Immunol       Date:  1953-01       Impact factor: 5.422

2.  Structural similarities between C6 and C7 of human complement.

Authors:  E R Podack; W P Kolb; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The ninth component of human complement: purification and physicochemical characterization.

Authors:  G Biesecker; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Gonococci in urethral exudates possess a virulence factor lost on subculture.

Authors:  M E Ward; P J Watt; A A Glynn
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

6.  Influence of colony type on susceptibility of gonococci to killing by human serum.

Authors:  J A McCutchan; S Levine; A I Braude
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

7.  The role of C9 in complement-mediated killing of Neisseria.

Authors:  G R Harriman; A F Esser; E R Podack; A C Wunderlich; A I Braude; T F Lint; J G Curd
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

8.  Clinical manifestations of disseminated infection caused by Neisseria gonorrhoeae are linked to differences in bactericidal reactivity of infecting strains.

Authors:  P A Rice; D L Goldenberg
Journal:  Ann Intern Med       Date:  1981-08       Impact factor: 25.391

9.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

10.  Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns.

Authors:  J Swanson; S J Kraus; E C Gotschlich
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  22 in total

1.  Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.

Authors:  M J Blaser; P F Smith; J E Repine; K A Joiner
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Resistance of Escherichia coli to osmotically introduced complement component C9.

Authors:  J R Dankert
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Experimental transmission of Neisseria gonorrhoeae from pregnant rat to fetus.

Authors:  S Nowicki; R Selvarangan; G Anderson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.

Authors:  M M Estabrook; J M Griffiss; G A Jarvis
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 5.  Systemic gonococcal infection.

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-12

6.  Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

Authors:  J E Schweinle; P J Hitchcock; A J Tenner; C H Hammer; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 7.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 8.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

9.  Gonococcal infection in a nonhuman host is determined by human complement C1q.

Authors:  S Nowicki; M G Martens; B J Nowicki
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.

Authors:  E J Heffernan; S Reed; J Hackett; J Fierer; C Roudier; D Guiney
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.